黒色腫治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Melanoma Biomarkers 29
3.2 Clinical Staging 30
3.3 Symptoms 32
3.4 Prognosis 32
3.5 Quality of Life 34
4 Epidemiology 35
4.1 Disease Background 35
4.2 Risk Factors and Comorbidities 35
4.3 Global Trends 38
4.3.1 US 39
4.3.2 5EU 39
4.3.3 Japan and Australia 39
4.4 Forecast Methodology 40
4.4.1 Sources Used 42
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods 49
4.5 Epidemiological Forecast for Melanoma (2013-2023) 52
4.5.1 Diagnosed Incident Cases of Melanoma 52
4.5.2 Age-Specific Diagnosed Incident Cases of Melanoma 54
4.5.3 Sex-Specific Diagnosed Incident Cases of Melanoma Skin Cancer 56
4.5.4 Age-Standardized Diagnosed Incidence Rates 58
4.5.5 Pathological Stage at Diagnosis 60
4.5.6 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer 61
4.5.7 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer by Genetic Aberrations 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 66
4.6.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis Overview 68
5.2 Treatment Overview 69
5.2.1 Localized Melanoma: Stage 0 to Stage IIC 71
5.2.2 Regional Melanoma: Stage IIIA to Stage IIIC 72
5.2.3 Unresectable and Metastatic Melanoma: Stage III and Stage IV 75
5.3 US 81
5.3.1 Screening and Diagnosis 82
5.3.2 Clinical Practices 84
5.4 France 86
5.4.1 Screening and Diagnosis 87
5.4.2 Clinical Practices 87
5.5 Germany 88
5.5.1 Screening and Diagnosis 89
5.5.2 Clinical Practices 90
5.6 Italy 93
5.6.1 Screening and Diagnosis 94
5.6.2 Clinical Practices 94
5.7 Spain 96
5.7.1 Screening and Diagnosis 97
5.7.2 Clinical Practices 97
5.8 UK 98
5.8.1 Screening and Diagnosis 99
5.8.2 Clinical Practices 99
5.9 Japan 101
5.9.1 Screening and Diagnosis 101
5.9.2 Clinical Practices 102
5.10 Australia 103
5.10.1 Screening and Diagnosis 104
5.10.2 Clinical Practices 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Interferon-based Adjuvant Therapies 110
6.2.1 Roferon-A (Interferon Alfa-2a) 110
6.2.2 Intron A (Interferon Alfa-2b) 114
6.2.3 Sylatron (Peginterferon Alfa-2b) 118
6.3 Immune Checkpoint Inhibitors 124
6.3.1 Yervoy (Ipilimumab) 124
6.3.2 Opdivo (Nivolumab) 134
6.3.3 Keytruda (Pembrolizumab) 143
6.4 BRAF Mutation-targeted Therapies 151
6.4.1 Zelboraf (Vemurafenib) 151
6.4.2 Tafinlar (Dabrafenib) 158
6.4.3 Mekinist (Trametinib) 164
6.5 Other Therapeutic Classes 176
7 Unmet Need and Opportunity 178
7.1 Overview 178
7.2 Therapeutic Options for BRAF Wild-Type Patients 180
7.2.1 Unmet Need 180
7.2.2 Gap Analysis 181
7.2.3 Opportunity 182
7.3 Therapies for Non-responders to PD-1 Immunotherapy 183
7.3.1 Unmet Need 183
7.3.2 Gap Analysis 184
7.3.3 Opportunity 186
7.4 Adjuvant Therapies for High-Risk Resectable Melanoma 188
7.4.1 Unmet Need 188
7.4.2 Gap Analysis 189
7.4.3 Opportunity 191
7.5 Effective Treatment for Brain Metastases 193
7.5.1 Unmet Need 193
7.5.2 Gap Analysis 194
7.5.3 Opportunity 196
7.6 Predictive Markers for Therapeutic Response to Immunotherapies 197
7.6.1 Unmet Need 197
7.6.2 Gap Analysis 198
7.6.3 Opportunity 200
8 Pipeline Assessment 201
8.1 Overview 201
8.2 Promising Drugs in Clinical Development 202
8.3 RAF/RAS/MEK Pathway-Targeting Therapies 204
8.3.1 Cobimetinib (GDC-0973) 204
8.3.2 Encorafenib (LGX818) 211
8.3.3 Binimetinib (MEK162) 217
8.4 Immune-Related Therapies 224
8.4.1 Talimogene Laherparepvec 224
8.4.2 Eltrapuldencel-T (NSB20) 232
8.4.3 Seviprotimut-L (POL-103A) 238
8.4.4 PV-10 244
8.5 Promising Drugs in Early-Stage Development 250
8.5.1 PI3K/Akt/mTOR Pathway-Targeting Therapies 250
8.5.2 Cell Cycle Checkpoint Inhibitors 252
8.5.3 Next-Generation BRAF Inhibitors 254
8.5.4 Immunotherapies 256
8.5.5 Antibody-Drug Conjugates 259
8.6 Other Drugs in Development 261
9 Current and Future Players 263
9.1 Overview 263
9.2 Trends in Corporate Strategy 266
9.3 Company Profiles 267
9.3.1 Bristol-Myers Squibb 267
9.3.2 Novartis 270
9.3.3 Roche 273
9.3.4 Merck 276
10 Market Outlook 280
10.1 Global Markets 280
10.1.1 Forecast 280
10.1.2 Drivers and Barriers — Global Issues 284
10.2 United States 286
10.2.1 Forecast 286
10.2.2 Key Events 290
10.2.3 Drivers and Barriers — US 291
10.3 5EU 293
10.3.1 Forecast 293
10.3.2 Key Events 297
10.3.3 Drivers and Barriers — France 298
10.3.4 Drivers and Barriers — Germany 300
10.3.5 Drivers and Barriers — Italy 301
10.3.6 Drivers and Barriers — Spain 303
10.3.7 Drivers and Barriers — UK 304
10.4 Japan 306
10.4.1 Forecast 306
10.4.2 Key Events 309
10.4.3 Drivers and Barriers — Japan 309
10.5 Australia 311
10.5.1 Forecast 311
10.5.2 Key Events 314
10.5.3 Drivers and Barriers — Australia 315
11 Appendix 317
11.1 Bibliography 317
11.2 Abbreviations 344
11.3 Methodology 349
11.4 Forecasting Methodology 349
11.4.1 Diagnosed Melanoma Patients 349
11.4.2 Percent Drug-Treated Patients 350
11.4.3 Drugs Included in Each Therapeutic Class 350
11.4.4 Launch and Patent Expiry Dates 351
11.4.5 General Pricing Assumptions 352
11.4.6 Average Body Weight and Surface Area Across the 8MM 353
11.4.7 Individual Drug Assumptions 354
11.4.8 Generic Erosion 368
11.4.9 Pricing of Pipeline Agents 368
11.5 Primary Research – KOLs Interviewed for this Report 370
11.6 Primary Research – Prescriber Survey 373
11.7 About the Authors 374
11.7.1 Analyst 374
11.7.2 Therapy Area Director 374
11.7.3 Epidemiologist 375
11.7.4 Global Head of Healthcare 375
11.8 About GlobalData 376
11.9 Disclaimer 376


【レポート販売概要】

■ タイトル:黒色腫治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2015年4月5日
■ 調査会社:GlobalData
■ 商品コード:GDHC104PIDR
■ 調査対象地域:グローバル
  • 物流の世界市場:2PL、3PL、4PL
    ABSTRACTAbout Logistics Logistics involve delivering, controlling, and planning of physical flow of goods, information exchange from the producer to a market as to meet the customer demands and outsourcing services that specializes in handling functions, such as transportation, warehousing, and freight and forwarding. Global logistics is the outsourcing of various elements of logistics and distrib …
  • 皮下埋め込み型ポートの世界市場2017-2021
    About Implantable Ports Implantable ports are thin, soft plastic tubes with a rubber disc at the end. Implantable ports are also called as subcutaneous ports or portacaths. They are most commonly inserted in patients undergoing chemotherapy. These ports are used to administer drugs to individuals. The diameter of the port ranges from 2.5 cm to 4 cm. Based on the product type, implantable ports can …
  • タンクレベルモニタリングシステムの世界市場:フロート/テープゲージング式、圧力式、超音波式、静電容量式、レーダー式レベルモニタリング装置
    Tank level monitoring systems (TLMSs) have applications across varied industry verticals, such as oil & fuel, chemical, mining, agriculture & husbandry, and automotive. The oil & fuel vertical is anticipated to be the leading application segment of the tank level monitoring system market. The global tank level monitoring system market is primarily driven by the lower installation cost of these sys …
  • RTD乳児用ミルクの世界市場2017-2021
    About RTD Infant Milk RTD infant milk is made of modified cow’s milk infused with vitamins, minerals, carbohydrates, and vegetable oils. Casein is the most significant protein in cow’s milk. However, the primary protein in breast milk is whey protein; hence many RTD infant milk formulas are predominantly altered to contain whey protein. Despite altering the milk formula with whey, milk formula dif …
  • 麻酔装置の世界市場2019-2023
    About this market The increasing number of surgeries requiring general anesthesia is one of the key factors expected to trigger the anesthesia devices market growth during the forecast period. General anesthesia is administered to the patients by medical practitioners for inducing unconsciousness during surgery and for post-surgery pain management. Anesthesia devices are also used for major operat …
  • オリゴヌクレオチド合成の世界市場
    Oligonucleotides are single-stranded and short RNA or DNA molecules with applications in research, forensics, and genetic testing. Oligonucleotides are made by chemical synthesis in the laboratory, and are used in therapeutics, cell cultures, library preparations, human identity testing, nucleic acid array-based technology, diagnostics, genetic engineering, next-generation sequencing, synthetic bi …
  • 鉛(Lead)の世界市場動向2014/2015
    The report presents a thorough study of lead, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing lead worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: lead production in the country, major manufacturers, lead …
  • Banzel / Inovelon (Epilepsy):市場予測と分析(~2022)
    Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure …
  • 世界の掘削機市場(2014-2018)
    About Excavator Market The The Global Construction Equipment market has experienced several pitfalls in the past decade due to the global economic recession. Excavators form an integral part of the Global Construction Equipment market; therefore, they experienced a decrease in their demand during the recession. There are two types of excavators: mini/midi excavators and crawler/wheeled excavators. …
  • スモールセル・バックホール(Small Cell Backhaul)のグローバル市場動向(2014-2019)
    Small cell backhaul solution refers to a set of equipments and services utilized to build a high capacity 3G/4G/LTE network for reliable communication infrastructure. The small cell technology solutions help operators to complement their existing network infrastructure by adding capacity with widespread coverage, supporting increased data traffic with no dropped calls, and high-speed data connecti …
  • 世界の海産食品市場のM&A動向(2014年7月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global fish & seafood market during July 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global fish & seafood market throughout the month. Additionally, the report provides an overview of all t …
  • 高等教育の世界市場2017-2021
    About Higher Education Education and initiatives pertaining to technology in education are being used at the national level and across different regions worldwide. These are not only driving changes in the learning processes but are also upgrading the administrative and assessment methodologies. A rise in the number of learning courses and diversity in the curriculum, which is driven by both the g …
  • ロシアの滅菌器市場見通し(~2021)
    Russia Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Russia Sterilization Equipment Market Outlook to 2021", provides key market data on the Russia Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and U …
  • 貿易金融商品の世界市場2015-2019
    About Trade Finance Trade finance is provided by banks to various trading companies for cross-border transactions. It drives the growth of a country's GDP. When a country produces goods or services, it exports some of those goods and services to other countries. However, there is a time lag between the production and delivery time, which leads to a certain degree of uncertainty about whether the p …
  • Hydroxypivalic acid neopentylglycol esterの世界市場
    Hydroxypivalic acid neopentylglycol ester (CAS 1115-20-4) Market Research Report 2014 presents comprehensive data on hydroxypivalic acid neopentylglycol ester markets globally and regionally (Europe, Asia, North America etc.) The report includes hydroxypivalic acid neopentylglycol ester description, covers its application areas and related patterns. It overviews hydroxypivalic acid neopentylglycol …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。